BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//ChamberMaster//Event Calendar 2.0//EN
METHOD:PUBLISH
X-PUBLISHED-TTL:P3D
REFRESH-INTERVAL:P3D
CALSCALE:GREGORIAN
BEGIN:VEVENT
DTSTART:20211020T160000Z
DTEND:20211020T170000Z
X-MICROSOFT-CDO-ALLDAYEVENT:FALSE
SUMMARY:SACC Houston: Houston Live is asking "What is the way forward for vaccine and m-RNA post Covid?"
DESCRIPTION:Virus and Vaccine manufacturing the future of Biotech and Contract Development and Manufacturing Organizations / CDMO's - what is the way forward for vaccine and m-RNA post Covid?\n\n\n\nJoin us for another installment of Houston Live\, a biweekly web series airing every other Wednesday at 11 am CST. In this series\, hear from Michael L. Stewart\, MS and Chief Technical Officer at Matica Biotechnology Inc.\, and a presentation by Christopher Westerlund\, Head of Finance at Matica. The event will be presented and moderated by Andr  Persson\, Chairman of the Board for SACC Houston.\n\n\n\nAbout Michael L. Stewart \n\nMichael L. Stewart has over 16 years of experience in the viral vector and vaccine production industry. Mike leads Matica Bio's technical functions including Process Engineering\, Process Development and Assay Development. Prior to joining Matica Bio\, Mike was the Director of Manufacturing for Fujifilm Diosynth Biotechnologies\, a CDMO providing manufacturing services to clients for virus-based vaccines products.\n\n \n\nIn addition to his three years at Fujifilm\, Mike has worked for protein and virus organizations including Boehringer-Ingelheim Biomanufacturing\, Meridian LifeScience\, and St. Jude's Children's Research Hospital (SJCRH).\n\n \n\nPrior to his time in the industry\, Mike completed Ph.D. Biochemistry studies at the University of Tennessee and St. Jude Children's Research Hospital focusing on the structural and functional amino acid substitutions that result in an oncogenic state. Mike served as a Medical Corpsman with the U.S. Navy / Marine Corps researching gravitational induced (rapid and gradual onset) loss of consciousness under Major General J.E. Whinnery\, PhD\, M.D. (retd.). Mike received his BS and MS degrees in Chemistry and Biochemistry from the Texas A&M University System.\n\n \n\nAbout Christopher Westerlund\n\nChristopher Westerlund is Head of Finance at Matica Biotech and is an executive with proven leadership in multiple public\, fortune 500\, private and private equity companies.\n\n \n\nHe has experience from strategic planning\, forecasting\, ROFO\, yearly plan\, 10+ years of FP&A management of $50M to $1.5 B. He has lead implementations\, process improvements including Lean Six Sigma and cross functional projects leadership\, as well as financial strategy\, profit improvement plans\, business cycle\, startup and business crisis management. Christopher has 15+ years of experience in the U.S.\,Latin America\, Europe and the Middle East\, and holds a Masters in Finance.\n\n\n\nSet a reminder or join us directly on Zoom on Wednesday\, October 20 at 11am CT\,\n\nhttps://us02web.zoom.us/j/83098607473?pwd=WTRER3ZsaU1NOC9jM3dVQSs3d3RXUT09
X-ALT-DESC;FMTTYPE=text/html:<br />\nVirus and Vaccine manufacturing the future of Biotech and Contract Development and Manufacturing Organizations / CDMO&rsquo\;s - what is the way forward for vaccine and m-RNA post Covid?<br />\n<br />\n<span style="font-size:14px\;"><span style="font-family:arial\;">Join us for another installment of <strong><em>Houston Live</em></strong>\, a biweekly web series airing every other Wednesday at 11 am CST. In this series\, hear from Michael L. Stewart\, MS and Chief Technical Officer at Matica Biotechnology Inc.\, and a presentation by Christopher Westerlund\, Head of Finance at Matica. The event will be presented and moderated by Andr&eacute\; Persson\, Chairman of the Board for SACC Houston.</span></span>\n<div style="color:rgb(40\, 63\, 115)\;font-family:-apple-system\, system-ui\, Helvetica Neue\, Segoe UI\, Arial\, sans-serif\;">\n<div><br />\n<span style="font-family:arial\;"><span style="color:#000000\;"><span style="font-size:14px\;"><strong>About&nbsp\;Michael L. Stewart&nbsp\;</strong></span></span></span></div>\n\n<div><span style="color:#000000\;"><span style="font-size:14px\;"><span style="font-family:arial\;">Michael L. Stewart has over 16 years of experience in the viral vector and vaccine production industry. Mike leads Matica Bio&rsquo\;s technical functions including Process Engineering\, Process Development and Assay Development. Prior to joining Matica Bio\, Mike was the Director of Manufacturing for Fujifilm Diosynth Biotechnologies\, a CDMO providing manufacturing services to clients for virus-based vaccines products.</span></span></span></div>\n\n<div><span style="color:#000000\;"><span style="font-size:14px\;"><span style="font-family:arial\;">&nbsp\;</span></span></span></div>\n\n<div><span style="color:#000000\;"><span style="font-size:14px\;"><span style="font-family:arial\;">In addition to his three years at Fujifilm\, Mike has worked for protein and virus organizations including Boehringer-Ingelheim Biomanufacturing\, Meridian LifeScience\, and St. Jude&rsquo\;s Children&#39\;s Research Hospital (SJCRH).</span></span></span></div>\n\n<div><span style="color:#000000\;"><span style="font-size:14px\;"><span style="font-family:arial\;">&nbsp\;</span></span></span></div>\n\n<div><span style="color:#000000\;"><span style="font-size:14px\;"><span style="font-family:arial\;">Prior to his time in the industry\, Mike completed Ph.D. Biochemistry studies at the University of Tennessee and St. Jude Children&#39\;s Research Hospital focusing on the structural and functional amino acid substitutions that result in an oncogenic state. Mike served as a Medical Corpsman with the U.S. Navy / Marine Corps researching gravitational induced (rapid and gradual onset) loss of consciousness under Major General J.E. Whinnery\, PhD\, M.D. (retd.). Mike received his BS and MS degrees in Chemistry and Biochemistry from the Texas A&amp\;M University System.</span></span></span></div>\n\n<div><span style="color:#000000\;"><span style="font-size:14px\;"><span style="font-family:arial\;">&nbsp\;</span></span></span><br />\n<strong style="color: rgb(0\, 0\, 0)\; font-family: arial\; font-size: 14px\;">About Christopher Westerlund</strong></div>\n\n<div><span style="color:#000000\;"><span style="font-size:14px\;"><span style="font-family:arial\;">Christopher Westerlund is Head of Finance at Matica Biotech and is an executive with proven leadership in multiple public\, fortune 500\, private and private equity companies.</span></span></span></div>\n\n<div><span style="color:#000000\;"><span style="font-size:14px\;"><span style="font-family:arial\;">&nbsp\;</span></span></span></div>\n\n<div><span style="color:#000000\;"><span style="font-size:14px\;"><span style="font-family:arial\;">He has experience from strategic planning\, forecasting\, ROFO\, yearly plan\, 10+ years of FP&amp\;A management of $50M to $1.5 B. He has lead implementations\, process improvements including Lean Six Sigma and cross functional projects leadership\, as well as financial strategy\, profit improvement plans\, business cycle\, startup and business crisis management. Christopher has 15+ years of experience in the U.S.\,Latin America\, Europe and the Middle East\, and holds a Masters in Finance.<br />\n<br />\nSet a reminder or join us directly on Zoom on Wednesday\, October 20 at 11am CT\,<br />\n<a href="https://us02web.zoom.us/j/83098607473?pwd=WTRER3ZsaU1NOC9jM3dVQSs3d3RXUT09">https://us02web.zoom.us/j/83098607473?pwd=WTRER3ZsaU1NOC9jM3dVQSs3d3RXUT09&nbsp\;</a></span></span></span></div>\n</div>\n\n<div style="color:rgb(40\, 63\, 115)\;font-family:-apple-system\, system-ui\, Helvetica Neue\, Segoe UI\, Arial\, sans-serif\;">&nbsp\;</div>\n
LOCATION:Join us directly on Zoom on Wednesday\, October 20 at 11am CT\, https://us02web.zoom.us/j/83098607473?pwd=WTRER3ZsaU1NOC9jM3dVQSs3d3RXUT09
UID:e.1936.4742
SEQUENCE:3
DTSTAMP:20260506T183506Z
URL:https://chamber.sacctx.com/events/details/sacc-houston-houston-live-is-asking-what-is-the-way-forward-for-vaccine-and-m-rna-post-covid-4742
END:VEVENT

END:VCALENDAR